Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2011
Endocrinology, Diabetes and Metabolism journal rankings 2011
111 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 111 ranked journals in 2011. The median OJR fell 0.05 on 2010 to 0.96, below the world average of 1.00; Q1 starts at OJR 1.47. The top three are Endocrine Reviews, Diabetes Care, and The Journal of Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
Show all 42 subfields
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
111 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 12.15Q1 | 23.92 4.44 down from 2010 | 98 | 65% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 4.14Q1 | 9.28 0.79 up from 2010 | 1,874 | 100% | — | ||
3The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.55Q1 | 7.54 0.29 down from 2010 | 2,218 | 54% | $3,750 | ||
4Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.42Q1 | 6.83 0.35 up from 2010 | 216 | 12% | $4,450 | ||
5Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.96Q1 | 5.61 0.40 down from 2010 | 145 | 11% | $3,540 | ||
6DiabetologiaSpringer Science+Business Media · Germany | 2.80Q1 | 6.69 0.36 down from 2010 | 1,075 | 88% | $3,490 | ||
7Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.56Q1 | 4.47 1.27 down from 2010 | 83 | 48% | $5,590 | ||
8Journal of Internal MedicineWiley · United Kingdom | 2.38Q1 | 5.02 0.48 down from 2010 | 457 | 56% | $4,780 | ||
9Endocrine Related CancerBioscientifica · United Kingdom | 2.35Q1 | 6.00 0.87 up from 2010 | 328 | 95% | — | ||
10Diabetes Obesity and MetabolismWiley · United Kingdom | 2.28Q1 | 5.06 0.22 up from 2010 | 488 | 17% | $5,380 | ||
11Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 2.24Q1 | 4.91 0.96 up from 2010 | 220 | 16% | — | ||
12EndocrinologyOxford University Press · United States | 2.15Q1 | 5.33 0.03 up from 2010 | 1,849 | 62% | $3,750 | ||
13European Journal of EndocrinologyOxford University Press · United Kingdom | 2.00Q1 | 4.37 0.04 up from 2010 | 827 | 24% | $4,292 | ||
14ThyroidMary Ann Liebert, Inc. · United States | 1.93Q1 | 4.99 0.92 up from 2010 | 669 | 18% | — | ||
15Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.92Q1 | 3.54 1.09 down from 2010 | 105 | 9% | — | ||
16Diabetes & MetabolismElsevier BV · Netherlands | 1.76Q1 | 2.83 1.18 down from 2010 | 326 | 2% | $4,490 | ||
17Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.73Q1 | 3.91 0.29 down from 2010 | 292 | 20% | $4,780 | ||
18Journal of EndocrinologyBioscientifica · United Kingdom | 1.72Q1 | 4.26 0.55 up from 2010 | 483 | 87% | — | ||
19Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.69Q1 | 4.42 0.48 up from 2010 | 194 | 100% | $4,290 | ||
20Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.64Q1 | —no 2010 value | 32 | — | $2,760 | ||
21International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.62Q1 | 3.26 1.30 up from 2010 | 60 | 100% | $2,830 | ||
22Chronic IllnessSAGE Publishing · United Kingdom | 1.61Q1 | 2.31 0.52 up from 2010 | 93 | 10% | $4,150 | ||
23BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.57Q1 | 3.98 0.41 up from 2010 | 63 | 100% | $3,190 | ||
24Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.56Q1 | 3.35 0.05 up from 2010 | 465 | 24% | $3,000 | ||
25Diabetic MedicineWiley · United Kingdom | 1.52Q1 | 3.21 0.49 down from 2010 | 856 | 26% | $4,870 | ||
26Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.51Q1 | 3.15 0.09 up from 2010 | 258 | 100% | $2,990 | ||
27Clinical EndocrinologyWiley · United Kingdom | 1.49Q1 | 3.46 0.11 up from 2010 | 811 | 25% | $4,250 | ||
28Clinical TherapeuticsElsevier BV · United States | 1.47Q1 | 3.04 0.10 down from 2010 | 777 | 17% | $4,240 | ||
29Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.43Q2 | 3.26 0.41 down from 2010 | 381 | 30% | — | ||
30Current Diabetes ReportsSpringer Science+Business Media · United States | 1.43Q2 | 3.24 0.36 up from 2010 | 234 | 27% | $4,890 | ||
31HORMONESSpringer Science+Business Media · Greece | 1.43Q2 | 3.47 0.81 up from 2010 | 118 | 100% | $2,390 | ||
32MaturitasElsevier BV · Netherlands | 1.42Q2 | 3.65 0.63 up from 2010 | 563 | 23% | $4,390 | ||
33Gender MedicineElsevier BV · United States | 1.38Q2 | 2.63 0.34 down from 2010 | 161 | 20% | — | ||
34Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.37Q2 | 3.22 0.52 down from 2010 | 613 | 27% | — | ||
35Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.31Q2 | 2.38 0.24 down from 2010 | 101 | 100% | $2,890 | ||
36Growth Hormone & IGF ResearchElsevier BV · United Kingdom | 1.29Q2 | 2.89 0.05 up from 2010 | 176 | 18% | $3,570 | ||
37Postgraduate MedicineTaylor & Francis · United States | 1.29Q2 | 2.70 0.27 up from 2010 | 334 | 5% | — | ||
38Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.26Q2 | 2.52 0.64 down from 2010 | 120 | 43% | $2,100 | ||
39Pediatric DiabetesWiley · Denmark | 1.26Q2 | 3.12 0.10 up from 2010 | 351 | 65% | $2,740 | ||
40The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.25Q2 | 2.82 0.04 down from 2010 | 224 | 20% | $4,400 | ||
41Clinical Drug InvestigationAdis, Springer Healthcare · New Zealand | 1.23Q2 | 2.50 0.02 up from 2010 | 270 | 5% | $4,190 | ||
42Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.23Q2 | 3.01 0.35 up from 2010 | 938 | 14% | $4,410 | ||
43Journal of Diabetes InvestigationOAAsian Association for the Study of Diabetes · Australia | 1.22Q2 | 2.74no 2010 value | 73 | 93% | $3,850 | — | |
44Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.19Q2 | 2.40 0.27 down from 2010 | 231 | 9% | $3,760 | ||
45Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.18Q2 | 2.69 0.25 up from 2010 | 476 | 22% | — | ||
46The Review of Diabetic StudiesOAGermany | 1.15Q2 | 2.68 0.83 up from 2010 | 75 | 97% | — | ||
47Endocrine JournalOAJapan Endocrine Society · Japan | 1.14Q2 | 2.78 0.21 up from 2010 | 434 | 99% | — | ||
48Endocrine PracticeElsevier BV · United States | 1.10Q2 | 2.77 0.57 up from 2010 | 551 | 9% | $3,480 | ||
49Endocrine Metabolic & Immune Disorders - Drug TargetsBentham Science Publishers · Netherlands | 1.10Q2 | 2.11 1.20 down from 2010 | 91 | 9% | — | ||
50PeptidesElsevier BV · United States | 1.06Q2 | 2.63 0.18 down from 2010 | 1,008 | 21% | $3,710 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
39 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 111
- Window papers (baseline)
- 53,888 +32.3% from indicator year 2008
- Median OJR
- 0.959 +5.5% from indicator year 2008
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.